Your GLP-1 receptor sensitivity will temporarily increase after a missed dose, which means your regular dose may feel stronger than usual when you resume
Metformin primarily reduces glucose production in the liver, while GLP-1s have broader effects on appetite, gastric emptying, and insulin/glucagon balance
On the other hand, INSL-5 targets a GPCR known as GPR142, also known as RXFP4, a receptor found to be expressed by the NCI-H716 cell line (54), and both and -cells in the pancreas, and its activation directly stimulates the expression of GLP-1 and insulin, representing a possible new pharmacological tool for the treatment of type 2 diabetes (77, 221), and supporting a possible role for INSL-5 in the incretin effect
doi: 10.2147/CLEP.S91125 35 World health organization collaborating centre for drug statistics methodology
No long-term data beyond 12 weeks is available, so the sustainability of results with continued use is unknown
Many side effects can be eased with simple diet and lifestyle adjustments , like eating smaller meals, staying hydrated, moving more, and avoiding rich or fatty foods